In European groups of individuals with genetically undecided optic neuropathies, authors recognized more than 60 cases harboring ACO2 variants, 50 of which carried dominant mutations, highlighting the important contribution of pathogenic ACO2 variants to dominant optic atrophy. The gene discussed is ACO2; the disease is optic atrophy.